(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

Cis-gem NAC well tolerated in MIBC patients.

What is it about?

NAC is recommended by multiple guidelines in treatment o MIBC. Recommendation are mainly based on different chemotherapy regimens. Cis-gem has been used in metastatic patients. We report national tolerability results with over 200 patients treated in NAC setting.

Why is it important?

Cis-gem has been shown similar efficacy to MVAC with better tolerability profile in metastatic MB patients. Despite the regimen has been used for a decade in Finland, thorough evaluation has been lacking. Our objective was to evaluate tolerability of cis-gem NAC treatment and identify potential risk factors for poor tolerance.

Read more on Kudos…
The following have contributed to this page:
Antti Salminen
' ,"url"));